US 9139529
Substituted quinoxalines as sodium channel modulators
granted A61KA61K31/47A61K31/4709
Quick answer
US patent 9139529 (Substituted quinoxalines as sodium channel modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/47, A61K31/4709, A61K31/498, A61P